Source comparison
Comparison Table: Hexarelin Dosing Protocols for Fat Loss Research
Before selecting a protocol, researchers must weigh GH pulse amplitude against receptor longevity and logistical feasibility. Single Morning Dose 200–300mcg 1× daily (fasted AM) 8–12× baseline 7–10 days before 40% decline Moderate to high (≥200mcg) High. Singl
This comparison does not assign a generated winner or score.
- Before selecting a protocol, researchers must weigh GH pulse amplitude against receptor longevity and logistical feasibility.
- Single Morning Dose
- 200–300mcg
- 1× daily (fasted AM)
- 8–12× baseline
- 7–10 days before 40% decline
- Moderate to high (≥200mcg)
- High. Single injection
- Produces highest peak GH but unsustainable beyond 10 days without receptor desensitization; best for short-term (≤2 week) studies
- Two-Dose Split
- 300mcg (150mcg × 2)
- 2× daily (AM fasted, PM pre-sleep)
- 5–7× baseline per pulse
- 12–16 days before 30% decline
- Low to moderate
- Moderate. Requires AM and PM dosing
- Balances convenience with sustained effect; suitable for 4–6 week protocols with 2-day weekend washouts
- Three-Dose Pulsatile
- 300mcg (100mcg × 3)
- 3× daily (AM, afternoon, pre-sleep)
- 4–6× baseline per pulse
- 18–24 days before 20% decline
- Low
- Low. Requires midday dosing
- Gold standard for 8–12 week fat loss research; mimics endogenous GH pulsatility with minimal cortisol interference and longest receptor viability
- Cycled High-Dose
- 400mcg (200mcg × 2)
- 2× daily, 5 days on / 2 off
- 7–10× baseline per pulse
- Maintained via cycling
- Moderate
- Moderate. Weekend breaks required
- Maximizes within-cycle lipolysis but requires strict adherence to washout schedule; effective when total study duration allows for multiple cycles